Market Introduction
Europe consists of five major countries namely Germany, France, UK, Italy, and Spain. The market is also evaluated for the rest of countries in Europe. The market is driven by the factors such as increasing prevalence of hospitals acquired urinary tract infection (UTI), innovative technology and products, increasing adoption of point-of-care urinalysis and growing number of initiatives for launch of highly automated instruments for better diagnosis advancement, in this region.
The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to the lockdown restrictions announced by many European countries that caused disruptions in manufacturing and supply chain operations. Additionally, scheduled appointments and health checkups have been delayed in many clinics. Patients with the UTI suffered the inadequate availability of medical staff providing therapeutic services to treat their conditions. With the number of rising cases, the healthcare workers had to switch between their roles to meet the demand for healthcare staff to manage COVID-19. Hence, it caused a significant decrease in elective procedures due to a lack of healthcare resources. According to National Kidney Foundation, patients hospitalized with COVID-19 are at considerable risk of developing acute kidney injury (AKI), resulting in severe illnesses and death. The COVID-19 patients with blood or protein in their urine need to be continuously monitored as they are at a high risk of developing chronic kidney disease. However, with the implementation of proper precautionary measures and modification of protocols to reduce the chances of exposure to SARS-CoV-2 during patient visits, the hospitals have begun to continue their operations, and a resurgence in testing numbers evident due to relaxations in restrictions imposed on people’s movement.
Market Overview and Dynamics
The urinalysis market in Europe is expected to grow from US$ 1,161.86 million in 2021 to US$ 1,655.73 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. A rise in the elderly population, increased prevalence of urinary tract infections, and kidney disorders are the major factors driving the urinalysis market's growth. As urine can be used to detect several diseases and diagnose conditions like urinary tract infections, kidney disorders, and diabetes, it is used for easy analysis of diseases. Also, the growing number of hospitals using new technologically advanced facilities in the region is likely to fuel the market's growth during the forecast period. The European Confederation of Laboratory Medicine (ECLM) has also provided stringent guidelines for Urinalysis. The European Urinalysis Guidelines are given under the auspices of the European Confederation of Laboratory Medicine, and these guidelines provide control on every aspect of urinalysis, including collection, preservation, and transport of urine specimens. Many countries are increasing their research and development to introduce innovative products. Therefore, it is expected that the increasing government initiatives and rising cases of UTI are likely to increase the urinalysis market growth during the forecast period.
Key Market Segments
Europe urinalysis market is segmented into product, test type, application, end user, and country. Based on product, the Europe urinalysis market is segmented into consumables and instruments. The consumables segment is expected to hold a larger market share in 2021. The Europe urinalysis market, based on test type, is segmented into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment would hold the largest share of the market in 2021. Based on application, the Europe urinalysis market is segmented into disease screening and pregnancy, and fertility. The disease screening segment would account for a larger market share in 2021. The Europe urinalysis market, by end user, is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021. Based on country, the Europe urinalysis market is segmented into France, Germany, Italy, Spain, the UK, and rest of Europe. Germany held the largest market share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the urinalysis market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; ACON Laboratories, Inc.; ARKRAY, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation.
Reasons to buy report
Europe Urinalysis Market Segmentation
Europe Urinalysis Market - By Product
Europe Urinalysis Market - By Test Type
Europe Urinalysis Market - By Application
Europe Urinalysis Market - By End User
Europe Urinalysis Market - By Country
Europe Urinalysis Market - Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,161.86 Million |
| Market Size by 2028 | US$ 1,655.73 Million |
| CAGR (2021 - 2028) | 5.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Urinalysis Market is valued at US$ 1,161.86 Million in 2021, it is projected to reach US$ 1,655.73 Million by 2028.
As per our report Europe Urinalysis Market, the market size is valued at US$ 1,161.86 Million in 2021, projecting it to reach US$ 1,655.73 Million by 2028. This translates to a CAGR of approximately 5.2% during the forecast period.
The Europe Urinalysis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Urinalysis Market report:
The Europe Urinalysis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Urinalysis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Urinalysis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Urinalysis Market
